Labeling Gaffe Sparks Mylan Drug Recall In Canada

Law360, New York (March 18, 2011, 3:21 PM EDT) -- Mylan Pharmaceuticals Inc.'s Canadian unit said Thursday it is voluntarily recalling some bottles of its Minocycline antibiotic drug and its Amlodipine hypertension drug because of a labeling mix-up reported by a pharmacist.

The recall includes all 100-count bottles of Mylan-Minocycline and Mylan-Amlodipine with product lot number 1037180 that were distributed to wholesalers and pharmacies, but does not include 250-count bottles carrying the same lot number, Mylan Pharmaceuticals ULC in Canada said.

Mylan launched the product call-back after a pharmacist who had received several bottles of Mylan-Minocycline...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.